Post-earnings recap
Reported
Thu, Jan 30, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Edwards Lifesciences reported an EPS that fell short of expectations, leading to a slight increase in stock price by 0.53%. The market reacted positively despite the earnings miss, likely due to management's focus on ongoing demand for their products and potential for future growth. Investors may be encouraged by the company's long-term outlook despite current challenges.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.46 | N/A | -4.47% |
Overall, management conveyed a cautious optimism about future demand while acknowledging current market challenges.
Management highlighted ongoing demand for their heart valve products.
They noted challenges in the market but expressed confidence in long-term growth.